Estrogen signaling is not required for prostatic bud patterning or for its disruption by 2,3,7,8-tetrachlorodibenzo-p-dioxin

Toxicology and Applied Pharmacology

Volumn 239, Issue 1, 2009, Pages 80-86

  Allgeier, Sarah Hicks ^a   Vezina, Chad M ^a   Lin, Tien Min ^a   Moore, Robert W ^a   Silverstone, Allen E ^b   Mukai, Motoko ^c   Gavalchin, Jerrie ^d   Cooke, Paul S ^c   Peterson, Richard E ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^d Department of Obstetrics Gynecology   (United States)

Author keywords

2,3,7,8 tetrachlorodibenzo p dioxin (TCDD); Estrogen receptor knockout mice; Estrogen signaling; ICI 182,780; Prostate development; Prostatic budding patterns

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; EMBRYO PATTERN FORMATION; MALE; MOUSE; NONHUMAN; PRENATAL DEVELOPMENT; PRENATAL EXPOSURE; PROSTATE; PROSTATE EPITHELIUM; SIGNAL TRANSDUCTION; UROGENITAL SINUS;

ANIMALS; ENDOCRINE DISRUPTORS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; FEMALE; GESTATIONAL AGE; MALE; MATERNAL EXPOSURE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUTATION; ORGANOGENESIS; PREGNANCY; PROSTATE; SIGNAL TRANSDUCTION; TETRACHLORODIBENZODIOXIN;

ANIMALIA; MUS; RATTUS;

EID: 67650762409     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2009.06.001     Document Type: Article

References (55)

1. Abbott B.D., Lin T.M., Rasmussen N.T., Albrecht R.M., Schmid J.E., and Peterson R.E. Lack of expression of EGF and TGF-α in the fetal mouse alters formation of prostatic epithelial buds and influences the response to TCDD. Toxicol. Sci. 76 (2003) 427-436
2. Allgeier S.H., Lin T.-M., Vezina C.M., Moore R.W., Fritz W.A., Chiu S.-Y., Zhang C., and Peterson R.E. WNT5A selectively inhibits mouse ventral prostate development. Dev. Biol. 324 (2008) 10-17
3. Benedict J.C., Lin T.-M., Loeffler I.K., Peterson R.E., and Flaws J.A. Physiological role of the aryl hydrocarbon receptor in mouse ovary development. Toxicol. Sci. 56 (2000) 382-388
4. Bookstaff R.C., Moore R.W., and Peterson R.E. 2,3,7,8-tetrachlorodibenzo-p-dioxin increases the potency of androgens and estrogens as feedback inhibitors of luteinizing hormone secretion in male rats. Toxicol. Appl. Pharmacol. 104 (1990) 212-224
5. Chen M., Hsu I., Wolfe A., Radovick S., Huang K., Yu S., Chang C., Messing E.M., and Yeh S. Defects of prostate development and reproductive system in the estrogen receptor-α null male mice. Endocrinology 150 (2009) 251-259
6. Couse J.F., Curtis S.W., Washburn T.F., Lindzey J., Golding T.S., Lubahn D.B., Smithies O., and Korach K.S. Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene. Mol. Endocrinol. 9 (1995) 1441-1454
7. Couse J.F., Hewitt S.C., Bunch D.O., Sar M., Walker V.R., Davis B.J., and Korach K.S. Postnatal sex reversal of the ovaries in mice lacking estrogen receptors α and β. Science 286 (1999) 2328-2331
8. Cunha G.R., Donjacour A.A., Cooke P.S., Mee S., Bigsby R.M., Higgins S.J., and Sugimura Y. The endocrinology and developmental biology of the prostate. Endocr. Rev. 8 (1987) 338-362
9. Dupont S., Krust A., Gansmuller A., Dierich A., Chambon P., and Mark M. Effect of single and compound knockouts of estrogen receptors α (ERα) and β (ERβ) on mouse reproductive phenotypes. Development 127 (2000) 4277-4291
10. Eddy E.M., Washburn T.F., Bunch D.O., Goulding E.H., Gladen B.C., Lubahn D.B., and Korach K.S. Targeted disruption of the estrogen receptor gene in male mice causes alteration of spermatogenesis and infertility. Endocrinology 137 (1996) 4796-4805
11. Fritz W.A., Lin T.-M., Moore R.W., Cooke P.S., and Peterson R.E. In utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure: effects on the prostate and its response to castration in senescent C57BL/6J mice. Toxicol. Sci. 86 (2005) 387-395
12. Greene R.R., Burrill M.W., and Ivy A.C. Experimental intersexuality. The effects of estrogens on the antenatal sexual development of the rat. Am. J. Anat. 67 (1940) 305-345
13. Greene R.R., Burrill M.W., and Ivy A.C. Experimental intersexuality: the effects of combined estrogens and androgens on the embryonic sexual development of the rat. J. Exp. Zool. 87 (1941) 211-232
14. Gupta C. Reproductive malformation of the male offspring following maternal exposure to estrogenic chemicals. Proc. Soc. Exp. Biol. Med. 224 (2000) 61-68
15. Hofkamp L., Bradley S., Tresguerres J., Lichtensteiger W., Schlumpf M., and Timms B. Region-specific growth effects in the developing rat prostate following fetal exposure to estrogenic ultraviolet filters. Environ. Health Perspect. 116 (2008) 867-872
16. Imamov O., Morani A., Shim G.-J., Omoto Y., Thulin-Andersson C., Warner M., and Gustafsson J.-Å. Estrogen receptor β regulates epithelial cellular differentiation in the mouse ventral prostate. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 9375-9380 Erratum in: Proc. Natl. Acad. Sci. U.S.A. 2006 103, 8298
17. Jarred R.A., McPherson S.J., Jones M.E., Simpson E.R., and Risbridger G.P. Anti-androgenic action by red clover-derived dietary isoflavones reduces non-malignant prostate enlargement in aromatase knockout (ArKO) mice. Prostate 56 (2003) 54-64
18. Ko K., Theobald H.M., and Peterson R.E. In utero and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in the C57BL/6J mouse prostate: lobe-specific effects on branching morphogenesis. Toxicol. Sci. 70 (2002) 227-237
19. Ko K., Theobald H.M., Moore R.W., and Peterson R.E. Evidence that inhibited prostatic epithelial bud formation in 2,3,7,8-tetrachlorodibenzo-p-dioxin-exposed C57BL/6J fetal mice is not due to interruption of androgen signaling in the urogenital sinus. Toxicol. Sci. 79 (2004) 360-369
20. Krege J.H., Hodgin J.B., Couse J.F., Enmark E., Warner M., Mahler J.F., Sar M., Korach K.S., Gustafsson J.-Å., and Smithies O. Generation and reproductive phenotypes of mice lacking estrogen receptor β. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 15677-15682
21. Lin T.-M., Ko K., Moore R.W., Simanainen U., Oberley T.D., and Peterson R.E. Effects of aryl hydrocarbon receptor null mutation and in utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on prostate and seminal vesicle development in C57BL/6 mice. Toxicol. Sci. 68 (2002) 479-487
22. Lin T.-M., Simanainen U., Moore R.W., and Peterson R.E. Critical windows of vulnerability for effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on prostate and seminal vesicle development in C57BL/6 mice. Toxicol. Sci. 69 (2002) 202-209
23. Lin T.-M., Rasmussen N.T., Moore R.W., Albrecht R.M., and Peterson R.E. Region-specific inhibition of prostatic epithelial bud formation in the urogenital sinus of C57BL/6 mice exposed in utero to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Sci. 76 (2003) 171-181
24. Lubahn D.B., Moyer J.S., Golding T.S., Couse J.F., Korach K.S., and Smithies O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 11162-11166
25. Marker P.C., Donjacour A.A., Dahiya R., and Cunha G.R. Hormonal, cellular, and molecular control of prostatic development. Dev. Biol. 253 (2003) 165-174
26. Matthews J., and Gustafsson J.-Å. Estrogen receptor and aryl hydrocarbon receptor signaling pathways. Nucl. Recept. Signal. 4 (2006) e016
27. McPherson S.J., Wang H., Jones M.E., Pedersen J., Iismaa T.P., Wreford N., Simpson E.R., and Risbridger G.P. Elevated androgens and prolactin in aromatase-deficient mice cause enlargement, but not malignancy, of the prostate gland. Endocrinology 142 (2001) 2458-2467
28. McPherson S.J., Ellem S.J., Simpson E.R., Patchev V., Fritzemeier K.H., and Risbridger G.P. Essential role for estrogen receptor β in stromal-epithelial regulation of prostatic hyperplasia. Endocrinology 148 (2007) 566-574
29. Nonneman D.J., Ganjam V.K., Welshons W.V., and Vom Saal F.S. Intrauterine position effects on steroid metabolism and steroid receptors of reproductive organs in male mice. Biol. Reprod. 47 (1992) 723-729
30. Ohtake F., Fujii-Kuriyama Y., and Kato S. AhR acts as an E3 ubiquitin ligase to modulate steroid receptor functions. Biochem. Pharmacol. 77 (2009) 474-484
31. Omoto Y. Estrogen receptor-α signaling in growth of the ventral prostate: comparison of neonatal growth and postcastration regrowth. Endocrinology 149 (2008) 4421-4427
32. Omoto Y., Imamov O., Warner M., and Gustafsson J.A. Estrogen receptor α and imprinting of the neonatal mouse ventral prostate by estrogen. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 1484-1489
33. Prins G.S., and Korach K.S. The role of estrogens and estrogen receptors in normal prostate growth and disease. Steroids 73 (2008) 233-244
34. Prins G.S., Huang L., Birch L., and Pu Y. The role of estrogens in normal and abnormal development of the prostate gland. Ann. N.Y. Acad. Sci. 1089 (2006) 1-13
35. Prins G.S., Tang W.-Y., Belmonte J., and Ho S.M. Perinatal exposure to oestradiol and bisphenol A alters the prostate epigenome and increases susceptibility to carcinogenesis. Basic Clin. Pharmacol. Toxicol. 102 (2008) 134-138
36. Prossnitz E.R., Arterburn J.B., Smith H.O., Oprea T.I., Sklar L.A., and Hathaway H.J. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu. Rev. Physiol. 70 (2008) 165-190
37. Raynaud A. Modification expérimentale de la différentiation sexuelle des embryos de souris par action des hormones androgènes et oestrogènes (primière et deuxième parties). Actual. Sci. Ind. 925 (1942) 1-264
38. Richter C.A., Timms B.G., and vom Saal F.S. Prostate development: mechanisms for opposite effects of low and high doses of estrogenic chemicals. In: Naz R.K. (Ed). Endocrine Disruptors (2nd Ed.). Effects on Male and Female Reproductive Systems (2005), CRC Press, Boca Raton 379-410
39. Risbridger G.P., Bianco J.J., Ellem S.J., and McPherson S.J. Oestrogens and prostate cancer. Endocr. Relat. Cancer 10 (2003) 187-191
40. Ruhlen R.L., Howdeshell K.L., Mao J., Taylor J.A., Bronson F.H., Newbold R.R., Welshons W.V., and vom Saal F.S. Low phytoestrogen levels in feed increase fetal serum estradiol resulting in the "fetal estrogenization syndrome" and obesity in CD-1 mice. Environ. Health Perspect. 116 (2008) 322-328
41. Safe S., Wang F., Porter W., Duan R., and McDougal A. Ah receptor agonists as endocrine disruptors: antiestrogenic activity and mechanisms. Toxicol. Lett. 102-103 (1998) 343-347
42. Timms B.G., Petersen S.L., and vom Saal F.S. Prostate gland growth during development is stimulated in both male and female rat fetuses by intrauterine proximity to female fetuses. J. Urol. 161 (1999) 1694-1701
43. Timms B.G., Peterson R.E., and vom Saal F.S. 2,3,7,8-tetrachlorodibenzo-p-dioxin interacts with endogenous estradiol to disrupt prostate gland morphogenesis in male rat fetuses. Toxicol. Sci. 67 (2002) 264-274
44. Timms B.G., Howdeshell K.L., Barton L., Bradley S., Richter C.A., and vom Saal F.S. Estrogenic chemicals in plastic and oral contraceptives disrupt development of the fetal mouse prostate and urethra. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 7009-7014
45. Tyl R.W., Myers C.B., Marr M.C., Sloan C.S., Castillo N.P., Veselica M.M., Seely J.C., Dimond S.S., Van Miller J.P., Shiotsuka R.N., Beyer D., Hentges S.G., and Waechter Jr. J.M. Two-generation reproductive toxicity study of dietary bisphenol A in CD-1 (Swiss) mice. Toxicol. Sci. 104 (2008) 284-362
46. Vannier B., and Raynaud J.P. Long-term effects of prenatal oestrogen treatment on genital morphology and reproductive function in the rat. J. Reprod. Fertil. 59 (1980) 43-49
47. Vezina C.M., Allgeier S.H., Moore R.W., Lin T.-M., Bemis J.C., Hardin H.A., Gasiewicz T.A., and Peterson R.E. Dioxin causes ventral prostate agenesis by disrupting dorsoventral patterning in developing mouse prostate. Toxicol. Sci. 106 (2008) 488-496
48. vom Saal F.S. Sexual differentiation in litter-bearing mammals: influence of sex of adjacent fetuses in utero. J. Anim. Sci. 67 (1989) 1824-1840
49. vom Saal F.S., Timms B.G., Montano M.M., Palanza P., Thayer K.A., Nagel S.C., Dhar M.D., Ganjam V.K., Parmigiani S., and Welshons W.V. Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 2056-2061
50. Wakeling A.E., and Bowler J. ICI 182,780, a new antioestrogen with clinical potential. J. Steroid Biochem. Mol. Biol. 43 (1992) 173-177
51. Wakeling A.E., Dukes M., and Bowler J. A potent specific pure antiestrogen with clinical potential. Cancer Res. 51 (1991) 3867-3873
52. Weihua Z., Mäkelä S., Andersson L.C., Salmi S., Saji S., Webster J.I., Jensen E.V., Nilsson S., Warner M., and Gustafsson J.-Å. A role for estrogen receptor β in the regulation of growth of the ventral prostate. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 6330-6335
53. Weihua Z., Lathe R., Warner M., and Gustafsson J.-Å. An endocrine pathway in the prostate, ERβ, AR, 5α-androstane-3β,17β-diol, and CYP7B1, regulates prostate growth. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 13589-13594
54. Welshons W.V., Thayer K.A., Judy B.M., Taylor J.A., Curran E.M., and vom Saal F.S. Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. Environ. Health Perspect. 111 (2003) 994-1006
55. -/- mice. J. Clin. Invest. 104 (1999) 895-901